A股異動 | 拓維信息(002261.SZ)漲逾4% 擁抱鴻蒙 加入原子開源基金會
格隆匯9月3日丨拓維信息(002261.SZ)漲逾4%,暫錄六連陽,報8.16元,總市值90億元。拓維信息昨晚發佈公吿稱,公司近日以銀牌捐贈人的身份加入開放原子開源基金會,併成為OpenHarmony項目羣成員,未來將主導成立OpenHarmony工業互聯網SIG和教育信息數據採集SIG,聚焦工業互聯網和教育信息化兩個行業,協同產業各方共同創新OpenHarmony應用場景,打造基於OpenHarmony的工業互聯網和教育行業發行版和行業泛終端,形成行業相關標準,以示範性標杆工程帶動行業國產化和產業化發展。市場人士稱,這表明拓維信息已成功躋身鴻蒙核心生態圈。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.